BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masood KI, Rottenberg ME, Carow B, Rao N, Ashraf M, Hussain R, Hasan Z. SOCS1 gene expression is increased in severe pulmonary tuberculosis. Scand J Immunol 2012;76:398-404. [PMID: 22670716 DOI: 10.1111/j.1365-3083.2012.02731.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mchenry ML, Simmons J, Hong H, Malone LL, Mayanja-kizza H, Bush WS, Boom WH, Hawn TR, Williams SM, Stein CM. Tuberculosis severity associates with variants and eQTLs related to vascular biology and infection-induced inflammation. PLoS Genet 2023;19:e1010387. [DOI: 10.1371/journal.pgen.1010387] [Reference Citation Analysis]
2 Mchenry ML, Simmons J, Hong H, Malone LL, Mayanja-kizza H, Bush WS, Boom WH, Hawn TR, Williams SM, Stein CM. Tuberculosis severity associates with variants and eQTLs related to vascular biology and infection-induced inflammation.. [DOI: 10.1101/2022.08.23.22279140] [Reference Citation Analysis]
3 Masood KI, Irfan M, Masood Q, Yameen M, Jamil B, Ram N, Rao S, Rottenberg M, Hasan Z. Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)‐3 in the diabetic host. Scand J Immunol. [DOI: 10.1111/sji.13134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Fu B, Lin X, Tan S, Zhang R, Xue W, Zhang H, Zhang S, Zhao Q, Wang Y, Feldman K, Shi L, Zhang S, Nian W, Chaitanya Pavani K, Li Z, Wang X, Wu H. MiR-342 controls Mycobacterium tuberculosis susceptibility by modulating inflammation and cell death. EMBO Rep 2021;:e52252. [PMID: 34288348 DOI: 10.15252/embr.202052252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li J, Cao C, Xiang Y, Hong Z, He D, Zhong H, Liu Y, Wu Y, Zheng X, Yin H, Zhou J, Xie H, Huang X. TLT2 Suppresses Th1 Response by Promoting IL-6 Production in Monocyte Through JAK/STAT3 Signal Pathway in Tuberculosis. Front Immunol 2020;11:2031. [PMID: 33042115 DOI: 10.3389/fimmu.2020.02031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Guo P, Qiao F, Huang D, Wu Q, Chen T, Badawy S, Cheng G, Hao H, Xie S, Wang X. MiR-155-5p plays as a "janus" in the expression of inflammatory cytokines induced by T-2 toxin. Food Chem Toxicol 2020;140:111258. [PMID: 32240701 DOI: 10.1016/j.fct.2020.111258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 McHenry ML, Williams SM, Stein CM. Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches. Infect Genet Evol 2020;81:104204. [PMID: 31981609 DOI: 10.1016/j.meegid.2020.104204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
8 Dupnik KM, Bean JM, Lee MH, Jean Juste MA, Skrabanek L, Rivera V, Vorkas CK, Pape JW, Fitzgerald DW, Glickman M. Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum. Int J Tuberc Lung Dis 2018;22:950-8. [PMID: 29991407 DOI: 10.5588/ijtld.17.0855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Soma S, Kawai S, Inada H, Watanabe K, Mizuno S, Kato S, Matsuo K, Yasutomi Y. Primary Role of Suppressor of Cytokine Signaling 1 in Mycobacterium bovis BCG Infection. Infect Immun 2018;86:e00376-18. [PMID: 30181351 DOI: 10.1128/IAI.00376-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Yuan Y, Lin D, Feng L, Huang M, Yan H, Li Y, Chen Y, Lin B, Ma Y, Ye Z, Mei Y, Yu X, Zhou K, Zhang Q, Chen T, Zeng J. Upregulation of miR-196b-5p attenuates BCG uptake via targeting SOCS3 and activating STAT3 in macrophages from patients with long-term cigarette smoking-related active pulmonary tuberculosis. J Transl Med 2018;16:284. [PMID: 30326918 DOI: 10.1186/s12967-018-1654-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
11 Harling K, Adankwah E, Güler A, Afum-Adjei Awuah A, Adu-Amoah L, Mayatepek E, Owusu-Dabo E, Nausch N, Jacobsen M. Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients. Cell Mol Immunol 2019;16:275-87. [PMID: 30886421 DOI: 10.1038/cmi.2018.5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
12 Duncan SA, Baganizi DR, Sahu R, Singh SR, Dennis VA. SOCS Proteins as Regulators of Inflammatory Responses Induced by Bacterial Infections: A Review. Front Microbiol 2017;8:2431. [PMID: 29312162 DOI: 10.3389/fmicb.2017.02431] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 9.7] [Reference Citation Analysis]
13 Lee SW, Liu CW, Hu JY, Chiang LM, Chuu CP, Wu LS, Kao YH. Suppressors of cytokine signaling in tuberculosis. PLoS One 2017;12:e0176377. [PMID: 28430824 DOI: 10.1371/journal.pone.0176377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Khan TA, Mazhar H, Saleha S, Tipu HN, Muhammad N, Abbas MN. Interferon-Gamma Improves Macrophages Function against M. tuberculosis in Multidrug-Resistant Tuberculosis Patients. Chemother Res Pract 2016;2016:7295390. [PMID: 27478636 DOI: 10.1155/2016/7295390] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
15 Masood KI, Pervez S, Rottenberg ME, Umar B, Hasan Z. Suppressor of cytokine signaling-1 and chemokine (C-X-C Motif) receptor 3 expressions are associated with caseous necrosis in granulomas from patients with tuberculous lymphadenitis. J Microbiol Immunol Infect 2016;49:984-7. [PMID: 26455487 DOI: 10.1016/j.jmii.2015.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Blok DC, Kager LM, Hoogendijk AJ, Lede IO, Rahman W, Afroz R, Bresser P, van der Zee JS, Ghose A, Visser CE, de Jong MD, Zahed AS, Husain MA, Alam KM, Barua PC, Hassan M, Hossain A, Tayab MA, Lutter R, Day N, Dondorp AM, de Vos AF, van 't Veer C, van der Poll T. Expression of inhibitory regulators of innate immunity in patients with active tuberculosis. BMC Infect Dis 2015;15:98. [PMID: 25887604 DOI: 10.1186/s12879-015-0833-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rottenberg ME, Carow B. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis. Seminars in Immunology 2014;26:518-32. [DOI: 10.1016/j.smim.2014.10.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
18 Rajaram MV, Ni B, Dodd CE, Schlesinger LS. Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol 2014;26:471-85. [PMID: 25453226 DOI: 10.1016/j.smim.2014.09.010] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 9.3] [Reference Citation Analysis]
19 Masood KI, Rottenberg ME, Salahuddin N, Irfan M, Rao N, Carow B, Islam M, Hussain R, Hasan Z. Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis. BMC Infect Dis 2013;13:13. [PMID: 23320781 DOI: 10.1186/1471-2334-13-13] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]